Trinity Legacy Partners’s CVS Health CVS Stock Holding History

Trinity Legacy Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,000	Closed	-$1K	–	110
2021 Q2	$1K	Buy	+1,000	New	+$81.9K	﹤0.01%	117

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Trinity Legacy Partners's CVS Position: Q2 2023 in Review

Trinity Legacy Partners sold out of CVS Health (CVS) in Q2 2023, closing a stake of 31,744 shares — an estimated $2.36M sold.

Trinity Legacy Partners first reported a position in CVS in Q1 2021 and held it in 9 quarters. The position peaked at $2.94M in Q1 2022. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

Trinity Legacy Partners reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
Trinity Legacy Partners sold 31,744 CVS Health shares in Q2 2023, an estimated $2.36M.
Trinity Legacy Partners first reported a position in CVS Health in Q1 2021 and held it in 9 quarters.
Trinity Legacy Partners's CVS Health position peaked at $2.94M in Q1 2022.
2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Trinity Legacy Partners's 13F filing for Q2 2023, filed 10 Jul 2023.